These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38003437)

  • 1. Non-Invasive Assessment of Skin Surface Proteins of Psoriasis Vulgaris Patients in Response to Biological Therapy.
    Orro K; Salk K; Merkulova A; Abram K; Karelson M; Traks T; Neuman T; Spee P; Kingo K
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of soluble skin surface protein levels for monitoring
    Orro K; Salk K; Abram K; Arshavskaja J; Meikas A; Karelson M; Neuman T; Kingo K; Spee P
    Front Med (Lausanne); 2023; 10():1072160. PubMed ID: 36936209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in Noninvasive Skin Biomarker Measurements in Daily Practice: A Longitudinal Study on Skin Surface Protein Detection by the Transdermal Analysis Patch in Pediatric Psoriasis.
    Schaap MJ; Bruins FM; van den Brink NJM; Orro K; Groenewoud HMM; de Jong EMGJ; van den Bogaard EH; Seyger MMB
    Skin Pharmacol Physiol; 2022; 35(6):319-327. PubMed ID: 36202075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin Surface Protein Detection by Transdermal Analysis Patches in Pediatric Psoriasis.
    Schaap MJ; Bruins FM; He X; Orro K; Peppelman M; van Erp PEJ; de Jong EMGJ; Koenen HJPM; van den Bogaard EH; Seyger MMB
    Skin Pharmacol Physiol; 2021; 34(5):271-280. PubMed ID: 34015784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface.
    Orro K; Smirnova O; Arshavskaja J; Salk K; Meikas A; Pihelgas S; Rumvolt R; Kingo K; Kazarjan A; Neuman T; Spee P
    Biomark Res; 2014; 2():20. PubMed ID: 25785188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-125a Correlates with Decreased Psoriasis Severity and Inflammation and Represses Keratinocyte Proliferation.
    Su F; Jin L; Liu W
    Dermatology; 2021; 237(4):568-578. PubMed ID: 33735868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the expression of the stromal cell-derived factor-1 alpha (CXCL 12) in psoriatic patients after treatment with Methotrexate.
    Abdelaal NH; Elhefnawy NG; Abdulmonem SR; Sayed S; Saleh NA; Saleh MA
    J Cosmet Dermatol; 2020 Jan; 19(1):253-258. PubMed ID: 31116013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of mRNA expression of survivin and human beta-defensin-3 in lesions of psoriasis vulgaris.
    Wang F; Zhang X; Xia P; Zhang L; Zhang Z
    Eur J Dermatol; 2016; 26(1):28-33. PubMed ID: 26771657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The investigation of antimicrobial peptides expression and its related interaction with methotrexate treatment in patients with psoriasis vulgaris.
    Ozlu E; Karadag AS; Ozkanli S; Oguztuzun S; Akbulak O; Uzuncakmak TK; Demirkan S; Akdeniz N
    Cutan Ocul Toxicol; 2017 Dec; 36(4):321-326. PubMed ID: 28067065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.
    Kolbinger F; Loesche C; Valentin MA; Jiang X; Cheng Y; Jarvis P; Peters T; Calonder C; Bruin G; Polus F; Aigner B; Lee DM; Bodenlenz M; Sinner F; Pieber TR; Patel DD
    J Allergy Clin Immunol; 2017 Mar; 139(3):923-932.e8. PubMed ID: 27502297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of skin surface biomakers by Transdermal Analyses Patch following different in vivo models of irritation: a pilot study.
    Falcone D; Spee P; Salk K; Peppelman M; van de Kerkhof PCM; van Erp PEJ
    Skin Res Technol; 2017 Aug; 23(3):336-345. PubMed ID: 27800639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the clinical response and changes in the expression of TNF-α and its TNFR1 and TNFR2 receptors in patients with psoriasis vulgaris treated with ustekinumab.
    Wcisło-Dziadecka DL; Grabarek B; Kruszniewska-Rajs C; Gola JM; Simka K; Mazurek U
    Adv Clin Exp Med; 2020 Feb; 29(2):235-241. PubMed ID: 32125100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local antimicrobial, protease and cytokine defense systems in psoriatic skin.
    Sidhom E; Pilmane M; Kisis J
    Indian J Dermatol Venereol Leprol; 2016; 82(3):284-91. PubMed ID: 27088930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin.
    Gambichler T; Skrygan M; Tomi NS; Othlinghaus N; Brockmeyer NH; Altmeyer P; Kreuter A
    Int Arch Allergy Immunol; 2008; 147(1):17-24. PubMed ID: 18446049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Malassezia in the activation of Interleukin (IL)-23/IL-17 axis in Psoriasis.
    Fang H; Hou Y; Zhuang H; Wang C
    New Microbiol; 2022 Apr; 45(2):130-137. PubMed ID: 35699562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
    Johnston A; Fritz Y; Dawes SM; Diaconu D; Al-Attar PM; Guzman AM; Chen CS; Fu W; Gudjonsson JE; McCormick TS; Ward NL
    J Immunol; 2013 Mar; 190(5):2252-62. PubMed ID: 23359500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine responses in nonlesional psoriatic skin as clinical predictor to anti-TNF agents.
    Tsoi LC; Patrick MT; Shuai S; Sarkar MK; Chi S; Ruffino B; Billi AC; Xing X; Uppala R; Zang C; Fullmer J; He Z; Maverakis E; Mehta NN; Perez White BE; Getsios S; Helfrich Y; Voorhees JJ; Kahlenberg JM; Weidinger S; Gudjonsson JE
    J Allergy Clin Immunol; 2022 Feb; 149(2):640-649.e5. PubMed ID: 34343561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.